{"id":"W2139264675","doi":"10.1016/j.jval.2014.03.1569","title":"Budget Impact Analysis Of Dolutegravir In The Treatment Of Human Immunodeficiency Virus (Hiv) In Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Medicine; Regimen; Formulary; Population; Pharmacy; Internal medicine; Human immunodeficiency virus (HIV); Pediatrics; Demography; Family medicine; Viral load; Environmental health; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003225995,0.0004744643,0.0009726199,0.002267958,0.001722279,0.002717754,0.00160331,0.0007507821,0.004115763],"category_scores_gemma":[0.01064445,0.0005964001,0.001294566,0.0049924,0.0007433553,0.0005651173,0.00110861,0.001119361,0.0001388832],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1736418,"about_ca_system_score_gemma":0.1770927,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9962687,"about_ca_topic_score_gemma":0.9976887,"domain_scores_codex":[0.9951119,0.001265641,0.0002586698,0.000151099,0.001454338,0.001758279],"domain_scores_gemma":[0.9923126,0.001550041,0.0008292888,0.0001161645,0.003382861,0.001809176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.008331073,0.001409809,0.4926207,0.003802693,0.003521404,0.002040571,0.001963068,0.276396,0.001616828,0.02828131,0.06715874,0.1128578],"study_design_scores_gemma":[0.001851253,0.001080815,0.8585315,0.001121974,0.001844771,0.0003654478,0.005239935,0.07895329,0.0006600412,0.002004168,0.04815107,0.0001957665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8933119,0.009179995,0.001053163,0.01344068,0.0001620169,0.001501701,0.03733367,0.00007346921,0.04394345],"genre_scores_gemma":[0.9854016,0.002949496,0.001069312,0.0006964816,0.00003097683,0.0001882433,0.003976419,0.00002000461,0.005667291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1736418,"threshold_uncertainty_score":0.9584584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02653231148149322,"score_gpt":0.305570767329171,"score_spread":0.2790384558476778,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}